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Histone acetylation is generally associated with active chromatin, but most studies have 26	
focused on the acetylation of histone tails. Various histone H3 and H4 tail acetylations 27	
mark the promoters of active genes1.  This includes acetylation of H3 on lysine 27 28	
(H3K27ac), which blocks the deposition of polycomb mediated H3K27me32. H3K27ac is 29	
also widely used to identify active enhancers3,4, and the assumption has been that 30	
profiling of H3K27ac is a comprehensive way of cataloguing the set of active enhancers 31	
in mammalian cell types. Here we show that acetylation of lysine residues in the 32	
globular domain of H3 (H3K64ac and H3K122ac) marks active gene promoters and 33	
also a subset of active enhancers. Moreover, we find a novel class of active functional 34	
enhancers that are marked by H3K122ac but lack H3K27ac. This work suggests that, to 35	
identify enhancers, a more comprehensive analysis of histone acetylation is required 36	
than was previously considered. 37	
Covalent modifications at the globular domains of the core histones have been implicated in a 38	
variety of chromatin functions5. Post-translational modifications (PTMs) located on the 39	
lateral (outer) surface of the histone octamer can alter contacts between the histones and the 40	
nucleosomal DNA and directly affect chromatin structure5. The acetylation of H3K56 41	
(H3K56ac) is associated with DNA unwrapping from the nucleosome and has been 42	
implicated in chromatin assembly and genome stability6. Acetylation of H3 at K64 43	
(H3K64ac), located at the start of the first alpha helix in the histone fold domain (HFD), 44	
destabilizes nucleosomes and facilitates nucleosome dynamics in vitro7. Methylation of the 45	
H3K64 is implicated in heterochromatin establishment8.  Histone – DNA interactions reach 46	
their maximum strength in the nucleosome dyad and, unlike acetylation on histone tails, 47	
H3K122ac is sufficient to stimulate transcription in vitro from chromatinized templates9 and 48	
promote nucleosome disassembly10.  49	
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Metagene analysis of H3K122ac and H3K64ac chromatin immunoprecipitation 50	
(ChIP) sequencing reads from mouse embryonic stem cells (mESCs) shows these marks 51	
correlate with the magnitude of gene expression (Fig. 1a). Surprisingly, given the link 52	
between histone acetylation and active chromatin, we find H3K122ac over a subset of 53	
inactive or poised genes that are repressed by polycomb complexes in mESCs (Fig. 1b,c).   54	
Sequential ChIP-qPCR confirmed the presence of H3K122ac on bivalently 55	
(H3K27me3/H3K4me3) marked nucleosomes (Fig. 1d). 56	
 Pearson correlation analysis across multiple histone modifications in mESCs indicates 57	
that H3K64ac and H3K122ac cluster with each other and with H3K4me1 (Fig. 1e) – a marker 58	
for enhancers11.  H3K122ac and H3K64ac reads were also enriched at active promoters and 59	
strong enhancers across hidden Markov model based chromatin states (ChromHmm)12,13 60	
(Supplementary Figure 1). Given this, we aligned H3K64ac, H3K122ac and H3K27ac ChIP-61	
seq data with the mid-point of enhancers in mESCs, as defined by the H3K4me1 peaks ± 2 kb 62	
away from RefSeq TSSs11 (Fig. 2a;). The data clustered into three groups (Supplementary 63	
dataset 1 based on the overlap of H3K4me1 peaks with those of H3K27ac and H3K122ac. 64	
Group 1, (n = 23,153) are H3K27ac+ and are, for the most part, also marked by significantly 65	
high levels of H3K122ac and H3K64ac (Wilcoxon sum rank test, Supplementary Table 1). 66	
This group of enhancers would be classified as active based upon their H3K27ac status3,4. At 67	
the other extreme, group 3 (n = 5,265) are negative for all three acetylation marks, and would 68	
be classified as inactive enhancers. Group 2 enhancers (n = 9,340) are negative for H3K27ac, 69	
but are marked by significantly high levels of H3K122ac and, a subset by H3K64ac. Using 70	
current methods, these would be classified as inactive enhancers. H3K122ac (which co-71	
occupies promoters with H2A.Zac9 and can induce transcription14) and H2A.Zac are 72	
comparably enriched in group 2 as in group 1 enhancers (Fig. 2b). Group 2 enhancers also 73	
have high levels of the EP300, which acetylates H3 at K64, K122 and K277,9,15.  74	
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We found that group 1 enhancers have high levels of H3K122ac and H3K64ac (Fig. 75	
2b). A subset of the clustered enhancers associated with highly expressed genes in ESCs, 76	
which have been termed ‘super-enhancers’ (SEs)16, were also heavily enriched with H3K64ac 77	
(Fig. 2a,d; Supplementary Figure 2). Our data suggest that there is a class of putative 78	
regulatory elements (Group 2, in Fig. 2) in mESCs that are marked by H3K122ac and/or 79	
H3K64ac but that lack H3K27ac that is usually used as a predictor of active enhancers. Gene-80	
Ontology (GO) analysis of subclasses indicates that both the H3K27ac+ and the H3K27ac–81	
/H3K122ac+ group of enhancers are associated with terms such as ‘stem-cell maintenance’. 82	
But the H3K27ac+ enhancers were also significantly enriched with terms associated with cell 83	
adhesion, which were lacking in the H3K122ac+/H3K27ac– set. Instead hindbrain 84	
morphogenesis, placental development and germ layer formation terms were prominent 85	
(Supplementary Figure 3a). A sub-class of group 2 enhancers, which are H3K27me3+, are 86	
enriched with terms associated with negative regulation of transcription, differentiation and 87	
development (Supplementary Figure 3b).   88	
Transcription factor (TF) motif enrichment analysis indicated SP1, SP2, SP4, KLF5, 89	
EGR1, TFAP2a, TFAP2b and TFAP2c binding sites, which we note generally have a high 90	
GC content, are enriched in group 2 enhancers (Supplementary Figure 4a). Compared to 91	
group 1 and group 3, group 2 enhancers also have higher levels of H3K27me3 and H2A.Z 92	
(Fig. 2b) – both markers for poised promoters and enhancers17,18. A subset of group 2 93	
enhancers with H3K27me3 peaks are enriched for un-methylated CpG islands (CGIs) 94	
(Supplementary Figure 4b, which are located at promoters and enhancers19. Bidirectional 95	
transcription of enhancers correlates with enhancer activity20, however these transcripts are 96	
degraded by the exosome complex making them difficult to detect. Analysis of Exosome 97	
sensitive RNAs (RNA seq reads from Exosome component 3 (Exosc3) knockout ESCs vs 98	
wild type)21 shows that group 2 enhancers transcribe high levels of Exosome sensitive 99	
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eRNAs (Fig. 2c).  100	
We tested the enhancer activity of these elements using luciferase reporter assays in 101	
mESCs; a well-characterized Nanog enhancer22 (Fig. 2d) served as a positive control. Group 102	
2 genomic regions (H3K27ac–) with enrichment for H3K122ac (Fig. 3a,b) exhibited 4 –120 103	
fold higher activity compared to negative controls and were equally, or more, active than the 104	
Nanog enhancer. Similarly, enhancer assays performed in a human breast adenocarcinoma 105	
cell line (MCF7) cells showed that H3K27ac–/H3K122ac+ enhancers9 display higher reporter 106	
activity than H3K27ac+ enhancers (Fig. 3c,d).  107	
To demonstrate the in vivo functional importance of group 2 enhancers, we used 108	
CRISPR/Cas923 to delete them from the ESC genome (Fig. 4a,b). As positive controls we 109	
also deleted one allele of the SE located near Nanog and Klf4 (Fig. 2c). This led to a 110	
significant reduction in Nanog and Klf4 expression, respectively (Fig. 4c), but not of Dppa3 – 111	
located 80kb upstream of Nanog.  Expression of Rad23b – 180 kb downstream of Klf4 is 112	
somewhat affected by the intervening enhancer deletion. Homozygous deletion of the 113	
putative group 2 enhancer 42kb downstream of Lif (Lif 42k en–/–) led to reduced expression 114	
of Lif, but not of the flanking gene Hormad2 (Fig. 4c).  Similarly, deletion of one allele of the 115	
putative enhancer 30kb upstream from Tbx3 (Tbx3 -30k en) led to down regulation of Tbx3. 116	
To examine whether histone acetylation is important for the function of these new 117	
regulatory elements we used dCas9 to recruit the Sid4x repressor complex24 to them (Fig. 118	
4d). As positive controls, recruitment of dCas9-Sid4x to the Nanog enhancer, and to the SE 119	
of Nanog Klf4, and Sox2, led to significant reduction in expression of the respective target 120	
genes but not other nearby genes (Fig. 4e). For the group 2 enhancers analysed, ChIP-qPCR 121	
showed that Sid4x recruitment effectively reduced the levels of H3K122ac at the target Tbx3 122	
-30k en, with no effect at the off-target control (Sox2 SE) (Fig. 4d). RT-qPCR analysis 123	
showed reduced expression of putative target genes upon Sid4x recruitment to Foxd3 -57k 124	
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en, Tbx3 -30k en, Sox2 40k en and Sox2 60k en, but not of the control genes (Fig. 4e). Sox2 125	
40k en also displayed higher activity in reporter assays (Fig. 3b).   126	
In order to investigate H3K122ac as an enhancer mark in more detail, we performed 127	
ChIP-seq for H3K122ac, H3K27ac and H3K4me1 in a human erythroleukemic (K562) cell 128	
line. As in ESCs, H3K122ac is enriched at active promoter, strong enhancer and poised 129	
promoter states (ChromHmm)12 in K562 cells (Fig. 5a,b). H3K122ac is also enriched at SEs, 130	
and H3K27ac+ enhancers (Fig. 5c-e). Similar to ESCs, a subset of H3K27ac– enhancers is 131	
marked with H3K122ac (Fig. 5c-e), is DHSs and bound by TFs (Fig. 5e, Supplementary 132	
dataset 2). TFs enrichment analysis of ENCODE ChIP-seq shows group 2 enhancers are 133	
enriched for CTCF, ZNF143, SMC3, RAD21, EZH2 and USF1 over group 1 (Supplementary 134	
Figure 4c). 135	
Rather than a simple definition of active enhancers as being marked by 136	
H3K4me1/H3K27ac, a more complex picture of different histone acetylation marks at 137	
enhancers is emerging25. Our data suggests that using H3K27ac alone gives an incomplete 138	
catalogue of the active enhancer repertoire, and that acetylation of H3 at the lateral surface of 139	
the histone octamer can be used to identify a novel class of active enhancers that have no 140	
significant H3K27ac enrichment.  141	
Lysine acetyl transferases (KATs) generally have relaxed substrate specificity, with 142	
the exception of KAT8, which acetylates H4K1625,26 and is critical for the maintenance of 143	
ESC pluripotency and differentiation27,28. H4K16ac marks active enhancers in ESCs, 144	
including some that lack H3K27ac25. Like the globular domain acetylations of H3, H4K16ac 145	
directly affects chromatin structure by perturbing inter-nucleosomal interactions in vitro29, 146	
but not higher-order chromatin structure25. The role of most histone acetylation marks at 147	
enhancers is unknown, but acetylation in the histone tails can recruit reader proteins such as 148	
BRD4 that are thought to be important for enhancer function30. This is unlikely to be the case 149	
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for H3K64 and H3K122 acetylation due to their location at the lateral surface of the histone 150	
octamer. Rather, acetylation of these residues is believed to function by directly altering 151	
nucleosomal stability and mobility, and by facilitating the binding of activators5. The finding 152	
of H4K16ac and H3 globular domain acetylations at enhancers suggests that opening of local 153	
chromatin structure might be an important facet of enhancer function and may stimulate the 154	
identification of yet more regulatory histone PTMs that directly affect the physical properties 155	
of the nucleosome. 156	
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Figure Legends  261	
 262	
 263	
Figure 1. Genomic distribution of H3K122ac and H3K64ac  264	
 265	
a) H3K122ac and H3K64ac native ChIP-seq reads per million (RPM) around (± 2kb) the 266	
transcription start (TSS) and end (TES) sites of genes, separated into quartiles according to 267	
gene expression in ESCs from low to high (Q1 – Q4) (n = 2 biological replicates).  268	
b) Heatmaps of H3K4me3, H3K27ac, H4K16ac, H3K64ac, H3K122ac, H2A.Zac, H2A.Z, 269	
H3K27me3 ChIP-seq, CAGE tags and input chromatin RPM around (± 2kb) TSS of 270	
polycomb repressed genes in ESCs.  271	
c) Reads per 10 million (RP10M) for ChIP-seq of H4K16ac, H3K27ac, H3K64ac, H2A.Z, 272	
H3K122ac, H3K4me3 and H3K27me3 across selected polycomb target genes Gsc, Hoxa9 273	
and Hoxa7 in ESCs. Genome co-ordinates are from the NCBI37/mm9 assembly of the mouse 274	
genome, CpG islands (CGI) and ChromHmm segmentation of these coordinates are shown 275	
below (purple=poised promoters; grey=heterochromatin)13.  276	
d) Sequential ChIP-qPCR over promoters of active genes – Sox2, Pou5f1, polycomb target 277	
genes – Msx1, Mash1, Hoxd1, Hoxa7, Cdx2, Gsc, and non-expressed gene Myf51. First ChIPs 278	
were performed with covalently coupled H3K4me3 (black bars) and H3K27me3 (dark grey 279	
bars) antibodies, followed by a second ChIP with H3K122ac antibodies (white and light grey 280	
bars for H3K4me3 and H3K27me3 first ChIP, respectively). Primer details given in 281	
Supplementary Table 2. Data is a representative of one of two experiments and error bars 282	
shows standard error of mean (s.e.m) from 3 technical replicates.  283	
e) Heatmap showing the hierarchical clustering of ChIP-seq data for H3K27me3, H3K4me3, 284	
H3K27ac, H3K4me1, H3K122ac and H3K64ac. Genome-wide Pearson’s correlation 285	
coefficient was calculated by dividing the genome into 10kb windows; correlation values 286	
among histone modifications are shown.   287	
 288	
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Figure 2. H3K122ac and H3K64ac marks active enhancers in ESC 289	
 290	
a) Heatmaps of ChIP-seq (RPM) fold change/input around (± 2kb) enhancer midpoints for 291	
H3K122ac, H3K27ac H3K64ac and H3K4me3 ordered from high to low H3K122ac. 292	
Enhancers were divided into three groups; 1 - H3K27ac peaks (H3K27ac+ active enhancers, 293	
n = 23,153), 2 - H3K122ac peaks but not H3K27ac (H3K122ac+/H3K27ac– enhancers, n = 294	
9,340), 3 - none of the above acetylation peaks (H3K27ac–/H3K122ac– inactive enhancers, n 295	
= 5,265). Similarly, heatmaps for mESC SEs16 are shown on top. Details of enhancer groups 296	
are listed in Supplementary dataset 1.  297	
b) Box plots showing log2 median interquartile distributions of RPM for the three enhancer 298	
groups, for H3K122ac, H3K27ac, H3K4me1, H3K64ac, H2A.Zac, H2A.Z, H3K27me3, 299	
H4K16ac, H3K4me1, and EP300 ChIP-seq data. Pairwise significance values were calculated 300	
using Wilcoxon rank sum test (Supplementary Table 1).   301	
c) Log2 RPM RNA seq reads from Exosome3 knockout ES cells (Exosc3–/–)/WT across the 302	
three enhancer groups in panel a. Reads from both negative (dotted) and positive (continuous) 303	
strands are shown.    304	
d) ChIP-seq data (RP10M) for histone marks across the genetically defined Nanog enhancer 305	
(Nanog en), SEs downstream of Klf4 (Klf4 SE), Sox2 (Sox2 SE) and the group 2 putative 306	
enhancers downstream of Sox2 (Sox2 40k en and Sox2 60k en). H3K27ac, H3K64ac, and 307	
H3K122ac ChIP-seq reads are averaged from two biological replicates and individual tracks 308	
for Nanog and Klf4 are shown in Supplementary Figure 2. DHS and ChromHmm are shown 309	
below the tracks, color-codes and enrichment values for histone marks across ESC 310	
ChromHmm states are in Supplementary Figure 1.  311	
 312	
Figure 3. In vitro enhancer assays  313	
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a) Similar to Fig. 2d, representative H3K27ac– putative Group 2 enhancers from ESC marked 314	
with H3K122ac (PE2 and PE5), and a negative control lacking all histone acetylation marks 315	
tested (C2). Regions used for cloning into the enhancer reporter vector (pGL4.26) are 316	
indicated by grey boxes and detailed in Supplementary Table 3.  317	
b) Luciferase reporter assays for genetically defined enhancer of Nanog (Fig. 2d) (Nan E), 318	
and randomly chosen H3K27ac negative putative active enhancers based on the presence of 319	
H3K122ac (PE1 – PE5, S40kE); H3K64ac (PE6, PE7); both H3K122ac and H3K64ac (PE8). 320	
Sox2 -40k enhancer (S40 kE) region is shown in Fig. 2d. Additionally, regions with 321	
H3K4me1 but no acetylation were assayed (C1, C2), and empty vector (pGL4.26) served as 322	
negative control. Mean Log2 fold change in luciferase activity was plotted with error bars 323	
showing standard error of mean (s.e.m) from two biological and 2 technical replicates (n = 4).  324	
c) Similar to a) but for putative enhancers from MCF7 cells9, transcription factor (TF) ChIP 325	
peaks from ENCODE are shown below. Genome co-ordinates are from the GRCh37/hg19 326	
assembly of the human genome. 327	
d) Similar to b) Luciferase assay done in MCF7 cells, for randomly chosen H3K27ac+ 328	
enhancers (G1E1, G1E2) and H3K122ac+/H3K27ac– putative human enhancers (PEh1 – 329	
PEh6). Nanog enhancer (Nan E) and vector alone served as controls. (Supplementary Table 330	
3. Mean log2 fold change in luciferase activity was plotted with error bars showing standard 331	
error of mean from two biological and 2 technical replicates (n = 4).  332	
 333	
Figure 4. In vivo function of group 2 enhancers in gene regulation 334	
a) RP10M, similar to Fig. 2d, but for selected candidate group 2 enhancer regions. Location 335	
of Cas9 gRNA targeting sites (arrow-heads) and dCas9-Sid4x (*) are indicated. Putative 336	
target (black) and non-target genes (grey) and the direction of transcription are indicated 337	
(arrows).  338	
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b) Schematic showing CRISPR/Cas9 mediated deletion strategy for enhancers.  339	
c) Mean (± s.e.m) expression of putative enhancer target genes, and flanking genes, assayed 340	
by RT-qPCR, normalized to Gapdh, in wild-type (WT) ESCs and in ES cells with 341	
heterozygous deletions of the Nanog and Klf4 SEs or homozygous deletions of the putative 342	
Group 2 enhancers. Lif 42k en, Foxd3 -20k en and Tbx3 -30k en (n = 3 biological replicates). 343	
gRNAs details are given in  Supplementary Table 4. 344	
d) Schematics showing dCas9-Sid4x recruitment to enhancers (left). Right; graph showing 345	
ChIP-qPCR (mean % input ± s.e.m, n = 3 technical replicates of 2 biological replicates) for 346	
H3K27ac and H3K122ac over Tbx3 -30k en, upon recruitment of dCas9-Sid4x to Tbx3 -30k 347	
en. Non-targeting (control) gRNA plasmids served as control.  Enrichment was compared to 348	
non-target Sox2 SE (right).  349	
e) As for (c), RT-qPCR for putative target genes Nanog, Klf4, Sox2, Foxd3 and Tbx3 (black) 350	
and neighboring control genes (grey) in cells transfected with dCas9-Sid4x along with gRNA 351	
plasmids targeting Nanog/Klf4/Sox2 SEs, Nanog en. Foxd3 -20k en, Tbx3 -30k en, Sox2 40k 352	
en and Sox2 60k en. Non-targeting (control) gRNA plasmids served as control, (n = 3 353	
biological replicates). gRNAs details are given in Supplementary Table 5. 354	
 355	
Figure 5. H3K122ac marks at K562 enhancers  356	
a) Enrichment values for H3K122ac, H3K27ac, H3K4me1, H3K27me3, H3K4me3 ChIPs 357	
and Input reads from K562 cells across ChromHmm segmentations12.   358	
b) Similar to panel a, boxplots showing log2 ChIP-seq RPM distributions (median value, line 359	
inside the box). The interquartile range (IQR) shows 50% of the data, the whiskers extend to 360	
1.5 x IQR.  361	
c and d) Heatmaps  and boxplots showing enrichment (RPM) of H3K122ac (red), H3K27ac 362	
(Orange) and H3K4me1 (black) in K562 cells across five groups of enhancers – grouped 363	
	 14	
based on the acetylation patterns. Super-enhancers (SE); enhancers marked with H3K27ac 364	
and H3K122ac (I); enhancers lacking H3K27ac but are marked with H3K122ac (II); 365	
enhancers with H3K27ac but not H3K122ac (III) and enhancers lack both H3K27ac and 366	
H3K122ac (IV). (Whiskers are as in panel b). 367	
e) UCSC genome browser tracks (RP10M) showing H3K27ac, H3K122ac, H3K4me1 ChIPs 368	
and input from K562 cells for SE and group I and II enhancers. TF ChIP, DHS clusters and 369	
K562 ChromHmm+Segway tracks are shown below (color code in Fig 5a). Genomic co-370	
ordinates of K562 cell enhancers are listed in Supplementary dataset 2.  371	
 372	
Online Methods 373	
Cell culture  374	
46C, Sox1-GFP mouse embryonic stem cells (mESC)31 were cultured as described 375	
previously25. Human erythro-myeloblastoid leukemia cells (K562) were cultured in RPMI 376	
1640 with L-Glutamine media containing 10% fetal bovine serum (FBS), L-glutamine, 377	
penicillin and streptomycin. Cell lines were validated and Mycoplasma tested at IGMM, 378	
University of Edinburgh.   379	
 380	
Sequential Chromatin Immunoprecipitation (ChIP) Antibodies recognizing H3K122ac 381	
and H3K64ac were previously described7,9.  mESCs were cross-linked in 1% formaldehyde 382	
for 10 min and then quenched by the addition of glycine to a final concentration of 0.125 M. 383	
Chromatin was sheared using a biorupter (Diagenode) to an average fragment length of ~100 384	
– 200bp. Sequential ChIP was performed as described previously32. Briefly, 5 µg antibodies 385	
against H3K4me3 (07-473, Millipore) and H3K27me3 (07-449, Millipore) were covalently 386	
coupled to Dynabeads using Invitrogen antibody coupling kit (Cat. 14311D) according to the 387	
manufacturer’s instructions. The first ChIP was performed using either H3K4me3 or 388	
H4K27me3 antibodies, and the immunoprecipitated chromatin was then eluted with 10 mM 389	
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DTT,	diluted 30 times with RIPA buffer (1X PBS, 1% NP-40, 0.5% Sodium Deoxycholate, 390	
0.1% SDS, *Roche Protease Inhibitor Cocktail) before performing the second ChIP with anti-391	
H3K122ac9. Purified chromatin was quantified by qPCR using the standard curve method 392	
and expressed as % of input bound. Primer details are given in Supplementary Table 2.   393	
 394	
Native Chromatin Immunoprecipitation 395	
10 x 106 mESCs and K562 cells were centrifuged at 500 g for 3 min, washed twice in PBS 396	
and then resuspended in 200 µl of NBA buffer [85 mM NaCl, 5.5 % Sucrose, 10 mM 397	
TrisHCl pH 7.5, 0.2 mM EDTA, 0.2 mM PMSF, 1 mM DTT, 1x Protease inhibitors 398	
(Calbiochem, 539134-1SET)]. Cells were lysed by the addition of an equal volume of NBA + 399	
0.1 % NP40 and incubated on ice for 3 min. Nuclei were pelleted at 2,000 g for 3 min at 4 ºC, 400	
then washed with NBR buffer (85 mM NaCl, 5.5 % Sucrose, 10 mM TrisHCl pH 7.5, 3 mM 401	
MgCl2, 1.5 mM CaCl2, 0.2 mM PMSF and 1 mM DTT) and pelleted at 2,000 g for 3 min at 4 402	
ºC. Nuclei were resuspended (10 x106 nuclei/ml) in NBR supplemented with RNaseA (20 403	
µg/ml) and incubated at 20 ºC for 5 min. Chromatin was fragmented for 30 min at 20 ºC 404	
using 0.133 U/µl microccocal nuclease (MNase - Boehringer units; SigmaAldrich - N3755-405	
500UN; titrated to give predominantly mono-nucleosomes). Digestion was stopped with the 406	
addition of an equal volume of STOP bufffer (215 mM NaCl, 10 mM TrisHCl pH 8, 20 mM 407	
EDTA, 5.5 %, Sucrose, 2 % TritonX 100, 0.2 mM PMSF, 1 mM DTT, 2X Protease 408	
Inhibitors) and digested nuclei left on ice overnight to release soluble, fragmented chromatin. 409	
Chromatin was pre-cleared by centrifugation at 12,000 g for 10 min at 4 ºC and the soluble 410	
chromatin (supernatant) transferred to a fresh tube. 5 % of the released chromatin was 411	
retained as input and the remainder incubated for 4 h at 4 ºC on a rotating wheel with ~5 µg 412	
of antibodies (H3K122ac9; H3K64ac7; H3K4me1 - Abcam ab8895, lot:GR251663-1; 413	
H3K27ac - Abcam ab4729, lot:GR254707-1) pre-coupled to protein A dynabeads (Life 414	
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Technologies; 10002D) in PBS containing 5 mg/ml BSA and 0.1 mM PMSF. Immune 415	
complexes bound to beads were washed 5x with wash buffer 1 (150 mM NaCl, 10 mM 416	
TrisHCl pH 8, 2 mM EDTA, 1 % NP40 and 1 % sodium deoxycholate) on a rotating wheel 417	
for 5 min each and once in room temperature TE buffer for 1 min. Chromatin was released 418	
from the beads by incubation with 0.1 M NaHCO3 / 1 % SDS for 30 min at 37 ºC followed by 419	
the addition of proteinase K (100 ug/ml) and Tris pH 6.8 (100 mM) and incubation at 55 ºC 420	
overnight. For both native and cross-linked ChIP, Dynabeads were removed using a magnetic 421	
rack and the chromatin purified using Qiaquick PCR Purification columns (Qiagen) 422	
according to the manufacturer’s instructions. 423	
ChIP-seq library preparation and Deep Sequencing 424	
Libraries were prepared as previously described33 with the following modifications: No 425	
purification was performed between the A-tailing and ligation reactions. After A-tailing 426	
reaction, enzymes were inactivated by incubation at 75 ºC for 20 min. and the ligation 427	
reaction was supplemented with ligation reagents [400 U of T4 DNA ligase (NEB), 1x buffer 428	
2 (NEB), 7.5 % PEG-6,000, 1 mM ATP and 13.3 nM of annealed Illumina adaptors (AU)] 429	
and incubated at 16 °C overnight. Size selection following the ligation and PCR steps was 430	
performed with 1x and 0.8x reaction volumes of Agencourt AMPure XP beads respectively 431	
(Beckman Coulter - A63880).  432	
Replicate 1 of the H3K122ac and H3K64ac ChIPs was sequenced at The Danish 433	
National High-Throughput DNA sequencing Center (Copenhagen; 42 base single end reads). 434	
Replicate 2 of the H3K122ac and H3K64ac ChIPs, 2 replicates of H3K27ac ChIPs and all 435	
ChIP and input samples prepared from K562 cells were sequenced at Edinburgh Genomics 436	
(The University of Edinburgh, 50 base single end reads).  437	
 438	
 439	
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Read mapping  440	
FASTQ files were aligned using Bowtie34 (version 0.12.8) with parameters set to retain 441	
uniquely mapped reads with a maximum of two mismatches (bowtie options: -e 40 -m 1 -v 442	
2). For mapping, mm9 and hg18 bowtie indexes were used for mouse (mESC) and human 443	
(K562 and MCF7) datasets respectively. Mapped reads from two biological replicates of 444	
H3K27ac, H3K122ac and H3K64ac were merged for further analysis.  445	
 446	
Peak calling 447	
Peaks were called using SICER35. For mESC, MNase-digested ChIP input DNA 448	
(GSM1156619) was used as a background control for H3K27ac, H3K64ac and H3K122ac. 449	
For H3K4me1 in ESCs (E14TG2a; GSM1003750), Input (GSM1003746) was used as a 450	
background control. mESC biological replicates were merged using SAMtools (v0.1.19) prior 451	
to peak calling with SICER (v1.1). SICER parameters: window size – 200 bp; fragment size 452	
– 150 bp; false discovery rate – 0.01; gap size – 600 bp for H3K122ac, H3K64ac, and 453	
H3K4me1 and a 200bp window size for H3K27ac.  454	
 455	
Generation of Bedgraphs for visualisation on UCSC genome browser 456	
Bedgraphs for each histone mark were generated from the aligned read files using the 457	
HOMER software suite (v4.7)36, at a resolution of 10 bp and with a normalized tag count of 458	
10 million. Mapped reads from two biological replicates for H3K122ac, H3K64ac and 459	
H3K27ac ChIPs in mESCs were combined for the generation of Bedgraphs for Figure 1 to 4. 460	
UCSC tracks for individual replicates covering representative loci are shown in 461	
Supplementary Figure 2. Similarly, data from single experiments for MCF7 and K562 462	
ChIPseq reads were processed to generate Bedgraphs for visualization in UCSC genome 463	
browser. 464	
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 465	
Heatmaps and average profiles  466	
Heatmaps and average profile for Refseq gene transcription start sites (TSS; ± 2kb), Refseq 467	
gene transcription end sites (TES; ± 2kb from), enhancer midpoints (± 2 kb from) and for 468	
entire length of super-enhancers (all scaled to an equivalent length ± 2 kb), were generated 469	
using ngsplot v2.6137.  470	
For Figure 1a, gene expression quartiles from high (Q4) to low (Q1) were obtained from our 471	
previous study25 and used to generate average profile plots for H3K122ac and H3K64ac 472	
across TSS and TES as detailed above. 473	
The Heatmap for Figure 1b was generated for TSSs (± 2kb) of genes which have been shown 474	
to be repressed by polycomb complexes38.  475	
The average profile plots (Figure 2a) for enrichment of strand specific RNA-seq reads in 476	
Exosc–/–/WT (SRP042355)21 for the 3 enhancer groups were generated using ngsplot37 477	
(v2.61). 478	
 479	
Genome-wide correlation analysis of histone marks. 480	
Pearson’s correlation coefficients were calculated between datasets using bamCorrelate tool39 481	
(version 1.5.9, removing duplicate reads and a using a resolution of 10 kb). The correlation 482	
matrix was hierarchically clustered and visualized using the Bioconductor package pheatmap. 483	
 484	
ChromHMM analysis 485	
To calculate the distribution of histone marks against different chromatin states the 486	
bamCorrelate tool was used to count reads within chromHMM segments for K56212 and 487	
mESCs13. Datasets were normalized to read per million (RPM). 488	
 489	
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Enhancer analysis 490	
Enhancers were defined as H3K4me1 peaks, with gene TSSs (RefSeq TSS ± 2kb) and 491	
genome blacklist40 regions removed.  Active enhancer regions (group 1) were defined as 492	
genomic intervals overlapping both H3K4me1 and H3K27ac peaks. Inactive enhancers, 493	
defined as peaks of H3K4me1 with no associated H3K27ac peak, were stratified into group 2 494	
and 3 representing those with and without an associated H3K122ac peak, respectively 495	
(Supplementary datasets 1 and 2). Peak intersections were performed using the BEDtools41 496	
(v2.23.0) intersect function. Super-enhancer co-ordinates for K562 cells and mESC were 497	
obtained from super-enhancer archive. H3K27me3 peak regions were called using MACS242 498	
(v2.1.0, broadpeak with no input control). 499	
 500	
TF motif enrichment analysis 501	
TF motif enrichment analysis was performed using the Regulatory Sequence Analysis Tools 502	
(RSAT) server. Nucleotide sequences from group 2 enhancers (H3K122ac+ in ESCs) were 503	
used as inputs for TF motif enrichment analysis with group 1 enhancer co-ordinates as the 504	
background. 505	
 506	
Gene ontology (GO) enrichment analysis 507	
Gene Ontology (Biological Process) enrichment analysis was performed using the Genomic 508	
Regions Enrichment of Annotations Tool (GREAT)43. Bed files from group1, group2 509	
enhancers intersecting with H3K27me3 peaks (H3K122ac+/H3K27me3+) and group2 510	
enhancers lacking H3K27me3 (H3K122ac+/H3K27me3–) were used as input and whole 511	
genome as background to select significantly enriched GO terms for nearby genes. 512	
 513	
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Enrichment analysis of DNaseI hypersensitivity sites (DHS) and un-methylated CpG 514	
islands (CGIs)19 515	
To determine the enrichment of DHS (GSM1014154) and CGIs at subgroups of enhancers; a 516	
Fisher’s exact test was performed using BEDtools fisher (default options) 41. Un-methylated 517	
CGI for mESCs were obtained from GSE43512. 518	
 519	
Dual luciferase enhancer assays  520	
Putative enhancer regions were PCR amplified from mouse (E14TG2a ESC) or human 521	
(HepG2) genomic DNA, cloned into pGL4.26 plasmid and sequence verified.  Details of 522	
enhancers and PCR products used in this assay are given in the Supplementary Table 3.  523	
Putative enhancers from mESCs were assayed in E14TG2a mESCs and putative MCF7 cell 524	
enhancers from were assayed in MCF7 cells. Forty-eight hours post-transfection, a luciferase 525	
assay was performed using the Dual-luciferase Reporter assay (Promega) as per the 526	
manufacturer’s instructions. Firefly luciferase activity was normalized to transfection 527	
efficiency with Renilla luciferase activity using pRL-TK. All values are shown as log2 ratios 528	
of enhancer activity vs. empty vector.  529	
 530	
Enhancer deletions 531	
Pairs of gRNAs (Supplementary Table 4) designed to direct Cas9 to regions flanking putative 532	
enhancers, were cloned into SpCas9-2A-GFP (PX458, Addgene number 48138) and 533	
transfected using lipofectamine 2000 (Invitrogen) into 46C ESCs44. 24 hours after 534	
transfection, transfected cells were FACS sorted for GFP + and are seeded at the 5,000 535	
cells/100mm dish. Surviving colonies were isolated and screened for deletion by PCR and 536	
homozygous clones were verified by Sanger sequencing. RT-qPCR was performed as 537	
	 21	
described previously32, altered gene expression upon deletion of enhancer elements was 538	
measured v/s wild type control.   539	
    540	
Sid4x recruitment to enhancers  541	
The repressive mSin3 Interaction Domain (Sid4x) was cloned C-terminal of dCas9 (pAC-542	
Sid4x) by replacing VP160 from dCas9VP160-2A-puro (pAC94)45. 2-3 guides per enhancer, 543	
or  5 – 7 guides per super-enhancer (Supplementary Table 5), were designed and oligos were 544	
synthesized from Sigma or IDT and cloned into pSLQ sgRNA expression plasmid as 545	
described46. All clones were verified by Sanger sequencing. Equal ratios of guideRNA pools 546	
and dCas9-Sid4x plasmids were co-transfected into mESCs using Lipofectamine 2000.  24 547	
hours after transfection puromycin (2µg/ml) was added to the media. Surviving transfected 548	
cells were harvested 48 hrs post transfection and RT-qPCR was performed as described32 and 549	
native ChIP was performed for H3K122ac and H3K27ac. ChIP enrichment was calculated as 550	
the percentage input bound by the standard curve method. As a control pAC-Sid4x was 551	
transfected along with non-targeting pSLQ sgRNA plasmid. 552	
 553	
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